Patheon, the Canadian drug maker with headquarters in Research Triangle Park, reported an operating loss in the first quarter as revenues declined 12 percent.
The company reported revenues of $153.9 million, down from $175.7 million during the same period a year ago.
Patheon had an operating loss of $20.9 million, compared to operating income of $13.5 million in the first quarter of last year.
The company manufactures prescription drugs and provides other services, such as developing the formulation of experimental drugs. It employs about 50 in RTP. None of Patheon's nine manufacturing facilities is based in the Triangle.




tchings Building, one of Research Triangle Park's most iconic landmarks.
